Antidepressants and gabapentinoids in neuropathic pain: mechanistic insights

M Kremer, E Salvat, A Muller, I Yalcin, M Barrot - Neuroscience, 2016 - Elsevier
Neuropathic pain arises as a consequence of a lesion or disease affecting the
somatosensory system. It is generally chronic and challenging to treat. The recommended …

Comprehensive review of cardiovascular toxicity of drugs and related agents

P Mladěnka, L Applová, J Patočka… - Medicinal research …, 2018 - Wiley Online Library
Cardiovascular diseases are a leading cause of morbidity and mortality in most developed
countries of the world. Pharmaceuticals, illicit drugs, and toxins can significantly contribute to …

Cardiovascular events associated with smoking cessation pharmacotherapies: a network meta-analysis

EJ Mills, K Thorlund, S Eapen, P Wu, JJ Prochaska - Circulation, 2014 - Am Heart Assoc
Background—Stopping smoking is associated with many important improvements in health
and quality of life. The use of cessation medications is recommended to increase the …

Depression and anxiety in heart failure

V Konstam, DK Moser, MJ De Jong - Journal of cardiac failure, 2005 - Elsevier
BACKGROUND: Although common among patients with heart failure, depression and
anxiety have been relatively neglected by researchers and practitioners. Both depression …

Australian and New Zealand clinical practice guidelines for the treatment of depression.

P Ellis - Australian & New Zealand Journal of Psychiatry, 2004 - search.ebscohost.com
Abstract The Royal Australian and New Zealand College of Psychiatrists (RANZCP) is
coordinating the development of clinical practice guidelines (CPGs) in psychiatry, funded …

The influence of selective serotonin reuptake inhibitors on human platelet serotonin

E Maurer-Spurej, C Pittendreigh… - Thrombosis and …, 2004 - thieme-connect.com
Clinical depression has been proposed to be an independent risk factor for cardiovascular
disease. While it is suggested that selective serotonin reuptake inhibitors (SSRIs) reduce the …

Improving general medical care for persons with mental and addictive disorders: systematic review

BG Druss, SA von Esenwein - General hospital psychiatry, 2006 - Elsevier
OBJECTIVE: To conduct a systematic review of studies of interventions designed to improve
general medical care in persons with mental and addictive disorders. METHODS: Following …

An evaluation of the cardiovascular safety profile of duloxetine: findings from 42 placebo-controlled studies

J Wernicke, A Lledo, J Raskin, DK Kajdasz, F Wang - Drug safety, 2007 - Springer
Background and objective: In recent years, new classes of medication, such as the serotonin-
noradrenaline reuptake inhibitors (SNRIs), have been developed for use in the treatment of …

Pathological laughing and crying: epidemiology, pathophysiology and treatment

HS Wortzel, TJ Oster, CA Anderson, DB Arciniegas - CNS drugs, 2008 - Springer
Pathological laughing and crying (PLC) is characterized by frequent, brief, intense
paroxysms of uncontrollable crying and/or laughing due to a neurological disorder. When …

Relevant issues in the monitoring and the toxicology of antidepressants

SMR Wille, SG Cooreman, HM Neels… - Critical reviews in …, 2008 - Taylor & Francis
This review provides specific information concerning the interpretation and usefulness of
antidepressant drug monitoring. Fifteen antidepressants (ADs) were selected based on their …